MCID: ADL008
MIFTS: 35

Adult Oligodendroglioma

Categories: Bone diseases, Cancer diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Adult Oligodendroglioma

MalaCards integrated aliases for Adult Oligodendroglioma:

Name: Adult Oligodendroglioma 12 15
Adult Brain Oligodendroglioma 12 71
Grade Ii Adult Oligodendroglial Tumor 12
Oligodendroglioma, Adult 71

Classifications:



External Ids:

Disease Ontology 12 DOID:3186
MeSH 43 D009837
NCIt 49 C4014 C9376
UMLS 71 C0279070 C1332190

Summaries for Adult Oligodendroglioma

MalaCards based summary : Adult Oligodendroglioma, also known as adult brain oligodendroglioma, is related to oligodendroglioma and diffuse intrinsic pontine glioma, and has symptoms including seizures and headache. An important gene associated with Adult Oligodendroglioma is KIAA1549 (KIAA1549), and among its related pathways/superpathways are Cell cycle_Chromosome condensation in prometaphase and Cytosine methylation. The drugs Donepezil and Fentanyl have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and bone.

Related Diseases for Adult Oligodendroglioma

Diseases in the Oligodendroglioma family:

Adult Oligodendroglioma

Diseases related to Adult Oligodendroglioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 76)
# Related Disease Score Top Affiliating Genes
1 oligodendroglioma 28.1 OLIG2 IDH2 IDH1 FUBP1 FGFR1 ATRX
2 diffuse intrinsic pontine glioma 10.3 H3-3B H3-3A
3 glial tumor 10.3 OLIG2 IDH1
4 enchondroma 10.3 IDH2 IDH1
5 bone giant cell sarcoma 10.3 H3-3B H3-3A
6 breast duct papilloma 10.3 IDH2 IDH1
7 malignant giant cell tumor 10.3 H3-3B H3-3A
8 telangiectatic osteogenic sarcoma 10.3 H3-3B H3-3A
9 cytogenetically normal acute myeloid leukemia 10.3 IDH2 IDH1
10 intracranial chondrosarcoma 10.3 IDH2 IDH1
11 tanycytic ependymoma 10.3 OLIG2 IDH1
12 central nervous system rhabdomyosarcoma 10.3 IDH2 IDH1
13 optic nerve neoplasm 10.3 OLIG2 KIAA1549
14 juvenile astrocytoma 10.3 KIAA1549 IDH1
15 periosteal chondrosarcoma 10.3 IDH2 IDH1
16 colon leiomyoma 10.3 H3-3B H3-3A
17 breast hemangioma 10.3 IDH2 IDH1
18 spinal cancer 10.3 KIAA1549 IDH1
19 juxtacortical chondroma 10.3 IDH2 IDH1
20 interval angle-closure glaucoma 10.3 IDH2 IDH1
21 gemistocytic astrocytoma 10.2 IDH2 IDH1
22 anaplastic oligodendroglioma 10.2 OLIG2 IDH2
23 brain stem cancer 10.2 H3-3B H3-3A
24 undifferentiated pleomorphic sarcoma 10.2 IDH2 IDH1
25 intraductal breast neoplasm 10.2 IDH2 IDH1
26 intraductal papilloma 10.2 IDH2 IDH1
27 multiple enchondromatosis, maffucci type 10.2 IDH2 IDH1
28 spindle cell hemangioma 10.1 IDH2 IDH1
29 clear cell ependymoma 10.1 OLIG2 KIAA1549 IDH1
30 d-2-hydroxyglutaric aciduria 1 10.1 IDH2 IDH1
31 cerebellum cancer 10.1 KIAA1549 IDH2 IDH1
32 2-hydroxyglutaric aciduria 10.1 IDH2 IDH1
33 bone giant cell tumor 10.1 H3-3B H3-3A
34 l-2-hydroxyglutaric aciduria 10.0 IDH2 IDH1
35 alpha thalassemia-x-linked intellectual disability syndrome 10.0 H3-3A ATRX
36 thoracic benign neoplasm 10.0 IDH2 IDH1
37 localized chondrosarcoma 10.0 IDH2 FGFR1
38 brain glioma 10.0 IDH2 IDH1 FUBP1
39 spinal cord astrocytoma 10.0 KIAA1549 IDH1 H3-3B H3-3A
40 childhood pilocytic astrocytoma 9.9 KIAA1549 IDH1 H3-3B H3-3A
41 spinal cord glioma 9.9 KIAA1549 IDH1 H3-3B H3-3A
42 malignant ependymoma 9.9 KIAA1549 IDH1 H3-3B H3-3A
43 pleomorphic xanthoastrocytoma 9.9 KIAA1549 IDH1 H3-3B H3-3A
44 enchondromatosis, multiple, ollier type 9.9 IDH2 IDH1 ATRX
45 breast benign neoplasm 9.9 IDH2 IDH1
46 infratentorial cancer 9.9 OLIG2 IDH1 H3-3B H3-3A
47 adult brain stem glioma 9.9 IDH2 IDH1 H3-3B H3-3A
48 clear cell chondrosarcoma 9.9 IDH2 IDH1 H3-3B H3-3A
49 temporal lobe neoplasm 9.9 IDH1 FUBP1 ATRX
50 chondroblastoma 9.9 H3-3B H3-3A FGFR1

Graphical network of the top 20 diseases related to Adult Oligodendroglioma:



Diseases related to Adult Oligodendroglioma

Symptoms & Phenotypes for Adult Oligodendroglioma

UMLS symptoms related to Adult Oligodendroglioma:


seizures, headache

Drugs & Therapeutics for Adult Oligodendroglioma

Drugs for Adult Oligodendroglioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 221)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Donepezil Approved Phase 3 120014-06-4 3152
2
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
3
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
4
Lomustine Approved, Investigational Phase 3 13010-47-4 3950
5
Temozolomide Approved, Investigational Phase 3 85622-93-1 5394
6
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
7
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
8 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
9 Analgesics Phase 3
10 Central Nervous System Depressants Phase 3
11 Nootropic Agents Phase 3
12 Liver Extracts Phase 3
13 Cholinergic Agents Phase 3
14 Cholinesterase Inhibitors Phase 3
15 Cola Phase 3
16 Narcotics Phase 3
17 Anesthetics Phase 3
18 Anesthetics, General Phase 3
19 Analgesics, Opioid Phase 3
20 Adjuvants, Anesthesia Phase 3
21 Anesthetics, Intravenous Phase 3
22 Antimitotic Agents Phase 3
23 Alkylating Agents Phase 3
24 Neurotransmitter Agents Phase 3
25 Central Nervous System Stimulants Phase 3
26 Dopamine Uptake Inhibitors Phase 3
27 Dexmethylphenidate Hydrochloride Phase 3
28 Dopamine Agents Phase 3
29
Ethanol Approved Phase 1, Phase 2 64-17-5 702
30
Levetiracetam Approved Phase 2 102767-28-2 441341
31
Pregabalin Approved, Investigational Phase 2 148553-50-8 5486971
32
Tamoxifen Approved Phase 2 10540-29-1 2733526
33
Cisplatin Approved Phase 2 15663-27-1 84093 441203 2767
34
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
35
Sodium citrate Approved, Investigational Phase 2 68-04-2
36
Aldesleukin Approved Phase 2 110942-02-4, 85898-30-2
37
Busulfan Approved, Investigational Phase 2 55-98-1 2478
38
Thiotepa Approved, Investigational Phase 2 52-24-4 5453
39
Modafinil Approved, Investigational Phase 2 68693-11-8 4236
40
Irinotecan Approved, Investigational Phase 2 97682-44-5, 100286-90-6 60838
41
Sirolimus Approved, Investigational Phase 1, Phase 2 53123-88-9 5284616 6436030 46835353
42
Everolimus Approved Phase 1, Phase 2 159351-69-6 6442177 70789204
43
Miconazole Approved, Investigational, Vet_approved Phase 1, Phase 2 22916-47-8 4189
44
Dasatinib Approved, Investigational Phase 2 302962-49-8 3062316
45
Bevacizumab Approved, Investigational Phase 2 216974-75-3
46
Topotecan Approved, Investigational Phase 2 119413-54-6, 123948-87-8 60700
47
Cyclophosphamide Approved, Investigational Phase 2 50-18-0, 6055-19-2 2907
48
Carmustine Approved, Investigational Phase 2 154-93-8 2578
49
Mercaptopurine Approved Phase 2 50-44-2 667490
50
Streptozocin Approved, Investigational Phase 2 18883-66-4 29327

Interventional clinical trials:

(show top 50) (show all 139)
# Name Status NCT ID Phase Drugs
1 Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
2 A Phase II Study of Observation in Favorable Low-Grade Glioma and a Phase II Study of Radiation With or Without PCV Chemotherapy in Unfavorable Low-Grade Glioma Completed NCT00003375 Phase 2, Phase 3 lomustine;procarbazine hydrochloride;vincristine sulfate
3 Primary Chemotherapy With Temozolomide Versus Radiotherapy in Patients With Low Grade Gliomas After Stratification for Genetic 1p Loss: A Phase III Study Completed NCT00182819 Phase 3 temozolomide
4 A Randomized, Double-blind, Placebo-controlled Multi-center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
5 Phase III Intergroup Randomized Comparison of Radiation Alone vs. Pre-Radiation Chemotherapy for Pure and Mixed Anaplastic Oligodendrogliomas Completed NCT00002569 Phase 3 lomustine;procarbazine hydrochloride;vincristine sulfate
6 PHASE III STUDY OF ADJUVANT PROCARBAZINE, CCNU AND VINCRISTINE CHEMOTHERAPY IN PATIENTS WITH HIGHLY ANAPLASTIC OLIGODENDROGLIOMA Completed NCT00002840 Phase 3 lomustine;procarbazine hydrochloride;vincristine sulfate
7 Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma Recruiting NCT00887146 Phase 3 concomitant temozolomide (TMZ);procarbazine;adjuvant temozolomide (TMZ);CCNU;vincristine
8 Phase III Study of Radiation Therapy With or Without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas Active, not recruiting NCT00978458 Phase 3 temozolomide
9 Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial. Active, not recruiting NCT00626990 Phase 3 temozolomide
10 A Phase III, Double-Blind, Prospective Randomized Clinical Trial of the Effect of D-threo-methylphenidate HCl (d-MPH) on Quality of Life in Brain Tumor Patients Receiving Radiation Therapy Terminated NCT00031798 Phase 3 methylphenidate hydrochloride
11 Phase III Randomized Evaluation of 13-Cis-Retinoic Acid (cRA) Plus Procarbazine Versus Procarbazine Alone in the Treatment of Patients With Recurrent Primary Malignant Gliomas Withdrawn NCT00003564 Phase 3 Isotretinoin;Procarbazine Hydrochloride
12 Phase I/II Study of Intratumoral Injection of DTI-015 Prior to Tumor Resection in Patients With Recurrent Malignant Glioma or Metastatic Neoplasm to Brain Unknown status NCT00009854 Phase 1, Phase 2 carmustine in ethanol
13 A Phase II Trial of Continuous Low-Dose Temozolomide for Patients With Recurrent Malignant Glioma Completed NCT00498927 Phase 2 temozolomide
14 Improved Characterization of Brain Tumors By MRI and MRS Completed NCT00274755 Phase 2 chemotherapy
15 PHASE I STUDY OF ANTI-TENASCIN MONOCLONAL ANTIBODY 131I 81C6 VIA SURGICALLY CREATED CYSTIC RESECTION CAVITY IN THE TREATMENT OF PATIENTS WITH PRIMARY OR METASTATIC MALIGNANT BRAIN TUMORS Completed NCT00002752 Phase 1, Phase 2
16 Levetiracetam and Pregabalin for Monotherapy in Patients With Brain Tumors and Seizures. A Phase II Randomized Study. Completed NCT00629889 Phase 2 levetiracetam;pregabalin
17 Cisplatin, Doxorubicin and Tamoxifen in the Treatment of Incurable Soft Tissue and Endocrine Malignancies Completed NCT00002608 Phase 2 cisplatin;doxorubicin hydrochloride;tamoxifen citrate
18 First Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors, a Phase II Trial Completed NCT00003731 Phase 2 temozolomide
19 Phase II Treatment of Adults and Children With Progressive Low Grade Gliomas With Temodal Completed NCT00003466 Phase 2 temozolomide
20 A Phase II Study of Temozolomide (TEMODAR) in the Treatment of Adult Patients With Supratentorial Low Grade Glioma Completed NCT00313729 Phase 2 temozolomide
21 Donepezil and EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases Completed NCT00070161 Phase 2 donepezil hydrochloride
22 Phase I/II Trial of Pyrazoloacridine and Carboplatin in Patients With Recurrent Glioma Completed NCT00005976 Phase 2 carboplatin;pyrazoloacridine
23 Immunotherapy for Malignant Glioma - Phase II Trial of Autologous Cancer Antigen Specific Immunotherapy Completed NCT00004024 Phase 2
24 A Phase II Trial of Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma Completed NCT00003101 Phase 2 busulfan;lomustine;procarbazine hydrochloride;thiotepa;vincristine sulfate
25 A Feasibility Study of Armodafinil for Brain Radiation-Induced Fatigue Completed NCT01032200 Phase 2 Armodafinil
26 A Phase II Trial of Irinotecan in Recurrent Glioma Completed NCT00003134 Phase 2 irinotecan hydrochloride
27 Phase I/Randomized Phase II Double Blind Study of Either Dasatinib or Placebo Combined With Bevacizumab in Recurrent Glioblastoma Completed NCT00892177 Phase 2 dasatinib
28 A Pilot Study of Tamoxifen, Carboplatin and Topotecan in the Treatment of Recurrent or Refractory Primary Brain or Spinal Cord Tumors or Metastatic Epithelial Cancers With Central Nervous System Metastases Completed NCT00541138 Phase 2 carboplatin;tamoxifen citrate;topotecan hydrochloride
29 CAMP 013:- Tandem Thiotepa Regimen For Selected Malignant Gliomas:1) Primary Or Recurrent Glioblastoma Multiforme (GBM); and 2) Recurrent Anaplastic Astrocytomas (AA), Oligodendrogliomas (O), Oligoastrocytomas (OA), Ependymomas And Primitive Neuroectodermal Tumors (PNET) That Have Either Progressed After Primary Therapy Or Are Refractory To Standard Chemotherapy Completed NCT00008008 Phase 2 cyclophosphamide;thiotepa
30 Phase I/II Trial of Irinotecan (CPT-11) in Patients With Recurrent Malignant Glioma Completed NCT00003616 Phase 1, Phase 2 irinotecan hydrochloride
31 Randomized Trial Assessing the Significance of Bevacizumab in Recurrent Grade II and Grade III Gliomas - The TAVAREC Trial Completed NCT01164189 Phase 2 Temozolomide
32 Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms Completed NCT00004688 Phase 2 carmustine;mercaptopurine;streptozocin
33 A Phase II Trial Of Pre-Irradiation And Concurrent Temozolomide In Patients With Newly Diagnosed Anaplastic Oligodendrogliomas And Mixed Anaplastic Oligoastrocytomas Completed NCT00033280 Phase 2 temozolomide
34 Phase II Trial of Continuous Dose Temozolomide in Patients With Newly Diagnosed Pure and Mixed Anaplastic Oligodendroglioma Completed NCT00400816 Phase 2 temozolomide
35 Bevacizumab in Combination With Irinotecan for Malignant Gliomas Completed NCT00268359 Phase 2 irinotecan hydrochloride
36 Open Label Phase II Study On STI571 (Glivec) Administered As A Daily Oral Treatment In Gliomas Completed NCT00039364 Phase 2 imatinib mesylate
37 A Phase II Study of Temozolomide (SCH 52365, Temodal(R)) for the Treatment of Recurrent Malignant Glioma Completed NCT00004113 Phase 2 temozolomide
38 A Multi-Center, Open-Label Clinical Study to Evaluate the Safety and Performance of the Proxima GliaSite RTS, a Radiation Delivery System, in Patients With Recurrent Malignant Brain Tumors Undergoing Surgical Resection Completed NCT00003574 Phase 2
39 Phase II Treatment of Adults With Recurrent Supratentorial Low Grade Glioma With Gliadel Wafers Completed NCT00003467 Phase 2 carmustine;polifeprosan 20 with carmustine implant
40 A Phase II Study of Topotecan in Patients With Anaplastic Oligodendroglioma or Anaplastic Mixed Oligoastrocytoma Completed NCT00003372 Phase 2 topotecan hydrochloride
41 Second Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors After PCV-Chemotherapy Completed NCT00003304 Phase 2 temozolomide
42 PHASE II STUDY OF CARBOPLATIN (CBDCA) IN THE TREATMENT OF CHILDREN AND ADULTS WITH PROGRESSIVE LOW GRADE GLIOMAS Completed NCT00002749 Phase 2 carboplatin
43 ANALYSIS OF THE EFFICACY OF SURAMIN IN RECURRENT MALIGNANT PRIMARY BRAIN TUMORS Completed NCT00002639 Phase 2 chemotherapy;suramin
44 A Phase II Trial Of Talampanel In Patients With Recurrent High-Grade Gliomas Completed NCT00064363 Phase 2 talampanel
45 Trial Of Oral Thalidomide, Celecoxib, Etoposide And Cyclophosphamide In Adult Patients With Relapsed Or Progressive Malignant Gliomas Completed NCT00047281 Phase 2 celecoxib;cyclophosphamide;etoposide;thalidomide
46 A Phase II Trial Of Thalidomide And Procarbazine In Adults With Recurrent/Progressive Gliomas Completed NCT00079092 Phase 2 procarbazine hydrochloride;thalidomide
47 A Phase I/II Trial of EMD 121974 for Treatment of Patients With Recurrent Anaplastic Gliomas Completed NCT00006093 Phase 1, Phase 2 cilengitide
48 Phase II Evaluation of Fenretinide NSC (374551) as a Single Agent in the Treatment of Adult Patients With Recurrent Malignant Glioma Completed NCT00006080 Phase 2 fenretinide
49 A Phase I/II Study of Oral Procarbazine in the Treatment of Recurrent High Grade Astrocytomas Completed NCT00004004 Phase 1, Phase 2 procarbazine hydrochloride
50 Phase II Study of Bevacizumab (Avastin) and BCNU for Treatment of Relapsed, High Grade Gliomas Completed NCT00795665 Phase 2 bevacizumab;carmustine

Search NIH Clinical Center for Adult Oligodendroglioma

Genetic Tests for Adult Oligodendroglioma

Anatomical Context for Adult Oligodendroglioma

MalaCards organs/tissues related to Adult Oligodendroglioma:

40
Brain, Spinal Cord, Bone, Breast, T Cells, Cerebellum, Liver

Publications for Adult Oligodendroglioma

Articles related to Adult Oligodendroglioma:

# Title Authors PMID Year
1
Pre- and post-surgery MRSI predictive value in adult oligodendroglioma prognosis. 61
29902567 2018
2
Outcomes and Prognostic Factors in Pediatric Oligodendroglioma: A Population-Based Study. 61
29131101 2018
3
Molecular characterization reveals NF1 deletions and FGFR1-activating mutations in a pediatric spinal oligodendroglioma. 61
27862886 2017
4
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology. 61
21069360 2011

Variations for Adult Oligodendroglioma

Expression for Adult Oligodendroglioma

Search GEO for disease gene expression data for Adult Oligodendroglioma.

Pathways for Adult Oligodendroglioma

Pathways related to Adult Oligodendroglioma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.47 H3-3B H3-3A
2
Show member pathways
9.74 IDH2 IDH1

GO Terms for Adult Oligodendroglioma

Cellular components related to Adult Oligodendroglioma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 nuclear chromosome, telomeric region GO:0000784 9.33 H3-3B H3-3A ATRX
2 nuclear nucleosome GO:0000788 9.26 H3-3B H3-3A
3 Barr body GO:0001740 8.96 H3-3B H3-3A
4 nuclear chromosome GO:0000228 8.8 H3-3B H3-3A ATRX

Biological processes related to Adult Oligodendroglioma according to GeneCards Suite gene sharing:

(show all 19)
# Name GO ID Score Top Affiliating Genes
1 cell proliferation GO:0008283 9.75 TACC1 H3-3B H3-3A
2 nucleosome assembly GO:0006334 9.65 H3-3B H3-3A ATRX
3 multicellular organism growth GO:0035264 9.61 H3-3B H3-3A ATRX
4 embryo implantation GO:0007566 9.58 H3-3B H3-3A
5 chromatin silencing at rDNA GO:0000183 9.57 H3-3B H3-3A
6 oogenesis GO:0048477 9.56 H3-3B H3-3A
7 tricarboxylic acid cycle GO:0006099 9.55 IDH2 IDH1
8 nucleus organization GO:0006997 9.54 H3-3B H3-3A
9 telomere organization GO:0032200 9.52 H3-3B H3-3A
10 muscle cell differentiation GO:0042692 9.51 H3-3B H3-3A
11 2-oxoglutarate metabolic process GO:0006103 9.49 IDH2 IDH1
12 NADP metabolic process GO:0006739 9.46 IDH2 IDH1
13 isocitrate metabolic process GO:0006102 9.4 IDH2 IDH1
14 pericentric heterochromatin assembly GO:0031508 9.37 H3-3B H3-3A
15 regulation of centromere complex assembly GO:0090230 9.32 H3-3B H3-3A
16 negative regulation of chromosome condensation GO:1902340 9.26 H3-3B H3-3A
17 telomeric heterochromatin assembly GO:0031509 9.16 H3-3B H3-3A
18 glyoxylate cycle GO:0006097 8.96 IDH2 IDH1
19 DNA replication-independent nucleosome assembly GO:0006336 8.8 H3-3B H3-3A ATRX

Molecular functions related to Adult Oligodendroglioma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 nucleosomal DNA binding GO:0031492 9.37 H3-3B H3-3A
2 NAD binding GO:0051287 9.32 IDH2 IDH1
3 RNA polymerase II core promoter sequence-specific DNA binding GO:0000979 9.26 H3-3B H3-3A
4 oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor GO:0016616 9.16 IDH2 IDH1
5 isocitrate dehydrogenase (NADP+) activity GO:0004450 8.96 IDH2 IDH1
6 isocitrate dehydrogenase activity GO:0004448 8.62 IDH2 IDH1

Sources for Adult Oligodendroglioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....